LSP Bio is a unique international consultancy that also offers select high quality healthcare products.

Our products: include a 'best of class' range of UK manufactured and CE approved hyaluronic acid (HA) products, enabling new standards of relief in everyday treatment in knee osteoarthritis (with RenehaVis™) as well as tennis elbow and ankle sprain (with SportVis™). Our website provides detailed information to healthcare providers, patients and procurement professionals, and we refer you to our product studies, practical support (e.g.videos demonstrating ease and safety of product use as well as mechanisms of action) and current case studies which confirm clinical, convenient (and economic) rationale for their use.

NOTE: A comment about HA products and NICE: Despite ongoing NICE negativity towards the HA class our own evidence, obtained via blinded, randomised and thorough clinical trials, which admittedly are not the norm in the HA category, confirms that some HA products at least, i.e. RenehaVis™ and SportVis™, do have strong and also clear pharmaceconomic clinical value (based on duration of effect rather than basic cost per treatment as NICE apply which disadvantages long acting products like RenehaVis™). This unwillingness by NICE to properly consider more recent and positive data due to our new improved product development, is at odds with ongoing international acceptance of our products. This is most recently shown by a new Italian 1214 patient 'community clinical report in everyday practice' showing significant and sustained knee pain reduction with RenehaVis™ up to and beyond 6 months - also significant German clinical and public feedback - all confirming our earlier pivotal study conclusions. (See Support section and 'RenehaVis/Healthcare Professionals Studies' page). However, if you need to know more please do not hesitate to contact us.

UK Product Availability: In addition to direct supply from LSP Bio for private patients with access to an injecting physician or physiotherapist our products are available via Drug Tariff/NHS and also NHS Supply Chain contract. (NB SportVis™ and RenehaVis™ were awarded 'Innovative Products' status as part of that NHS Supply Chain process).

Latest LSP Bio News:

* SportVis™ and RenehaVis™ UK Drug Tariff approved (ClassIXA - Devices) - RenehaVis™ as the only dual MW product in 'synovial fluids' class.

* 12 month efficacy CE-approved for single treatment RenehaVis™ in knee pain and joint degeneration, the longest for any HA product. Plus new SportVis™ data released in rotator cuff tendinopathy.

* SportVis™ awarded own class (Sodium Hyaluronate) in UK Drug Tariff due to its unique ankle and elbow indications.

RenehaVis™ provides the longest, strongest, fastest relief from pain and stiffness (and the most economic and convenient annualised benefit versus other products) due to knee joint degeneration and osteoarthritis


SportVis™ is a unique product offering the only evidence based and approved benefit to tennis elbow (extended relief) and ankle sprain (faster recovery and reduced incidence of recurrence)